유전자 치료 시장 규모, 점유율 및 성장 분석 : 유전자 유형별, 치료법별, 벡터 유형별, 전달 방법별, 투여 경로별, 용도별, 지역별 - 업계 예측(2026-2033년)

Global Gene Therapy Market size was valued at USD 9.00 Billion in 2024 and is poised to grow from USD 10.93 Billion in 2025 to USD 51.55 Billion by 2033, growing at a CAGR of 21.4% during the forecast period (2026-2033).

The global gene therapy market is witnessing robust expansion driven by significant scientific advancements and the rising prevalence of genetic disorders. Increasing rates of rare and chronic conditions, such as hemophilia and cystic fibrosis, are catalyzing the development of targeted gene-based therapies. Innovations like CRISPR-Cas9 and adeno-associated virus vectors have improved the precision and safety of gene delivery methods. Regulatory endorsements of prominent therapies have spurred further investment and research. However, challenges remain, including high treatment costs that limit accessibility, complex production of viral vectors, safety concerns regarding immune responses, and regulatory hurdles, particularly in emerging markets. Despite these constraints, ongoing clinical trials and technological integrations, alongside increased funding, hint at a promising trajectory for the market's future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Therapy Market Segments Analysis

The global gene therapy market is segmented by Gene Type, Therapy type, Vector type, Delivery Method, Route Of Administration, Application, End-user and region. Based on Gene Type, the market is segmented into Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Receptors and Others. Based on Therapy type, the market is segmented into Gene silencing therapy, Cell replacement therapy, Gene augmentation therapy and Other therapies. Based on Vector type, the market is segmented into Viral vector and Non-Viral Vector. Based on Delivery Method, the market is segmented into Ex-Vivo and In-Vivo.

Driver of the Global Gene Therapy Market

The expanding global gene therapy sector is significantly influenced by swift progress in gene editing techniques, particularly tools like CRISPR-Cas9. These innovative technologies enhance the precision, effectiveness, and safety of genetic modifications, thereby streamlining the clinical development process and broadening treatment options for patients. Furthermore, the development of vector-based methods coupled with improved delivery mechanisms is further driving growth in this field. As these advancements continue to evolve, they pave the way for a transformative impact on the therapeutic landscape, enabling researchers and healthcare providers to explore new possibilities in treating genetic disorders and enhancing patient outcomes.

Restraints in the Global Gene Therapy Market

The growth of the global gene therapy market faces various constraints, including concerns related to long-term safety, off-target effects, and ethical implications. These apprehensions may lead to skepticism among the public and regulatory bodies, potentially stalling the adoption of innovative therapies. Additionally, such uncertainties could deter investment and inhibit overall market development as stakeholders navigate the complexities surrounding genetic engineering. The combination of these factors can create significant challenges for the advancement and acceptance of gene therapies, ultimately impacting their potential to revolutionize treatment options in the healthcare sector.

Market Trends of the Global Gene Therapy Market

A significant trend in the global gene therapy market is the increasing focus on precision medicine, driven by advancements in genomics and biotechnology. This shift is enabling the development of targeted therapies that cater to individual genetic profiles, enhancing treatment efficacy and safety. Additionally, the rising prevalence of genetic disorders and chronic diseases is propelling investment in gene therapies, as stakeholders recognize their potential to address unmet medical needs. Collaborations between pharmaceutical companies and research institutions are also on the rise, facilitating innovation and accelerating the commercialization of gene therapies, thereby expanding access and improving patient outcomes globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Gene Therapy Market Size by Gene Type & CAGR (2026-2033)

• Market Overview
• Antigen
• Cytokine
• Tumor Suppressor
• Suicide
• Deficiency
• Receptors
• Others

Global Gene Therapy Market Size by Therapy type & CAGR (2026-2033)

• Market Overview
• Gene silencing therapy
• Cell replacement therapy
• Gene augmentation therapy
• Other therapies

Global Gene Therapy Market Size by Vector type & CAGR (2026-2033)

• Market Overview
• Viral vector
  • Retroviral vectors
  • AAV Vectors
  • Others
• Non-Viral Vector
  • Oligonucleotide Vectors
  • Others

Global Gene Therapy Market Size by Delivery Method & CAGR (2026-2033)

• Market Overview
• Ex-Vivo
• In-Vivo

Global Gene Therapy Market Size by Route Of Administration & CAGR (2026-2033)

• Market Overview
• Intravenous Route
• Subcutaneous Route
• Others

Global Gene Therapy Market Size by Application & CAGR (2026-2033)

• Market Overview
• Oncological Disorders
• Rare Diseases
• Cardiovascular Diseases
• Neurological Disorders
• Infectious Disease
• Other Diseases

Global Gene Therapy Market Size by End-user & CAGR (2026-2033)

• Market Overview
• Cancer Institutes
• Hospitals
• Research institutes
• Others

Global Gene Therapy Market Size & CAGR (2026-2033)

• North America (Gene Type, Therapy type, Vector type, Delivery Method, Route Of Administration, Application, End-user)
  • US
  • Canada
• Europe (Gene Type, Therapy type, Vector type, Delivery Method, Route Of Administration, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Gene Type, Therapy type, Vector type, Delivery Method, Route Of Administration, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Gene Type, Therapy type, Vector type, Delivery Method, Route Of Administration, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Gene Type, Therapy type, Vector type, Delivery Method, Route Of Administration, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Krystal Biotech (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CRISPR Therapeutics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beam Therapeutics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intellia Therapeutics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Korro Bio (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neurogene (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sangamo Therapeutics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MeiraGTx (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Verve Therapeutics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prime Medicine (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taysha Gene Therapies (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• enGene (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Voyager Therapeutics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Poseida Therapeutics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• uniQure (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Editas Medicine (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Benitec Biopharma (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellectis S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adverum Biotechnologies (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Generation Bio (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations